(Q53539702)
Statements
Relapse risk after autologous transplantation in patients with newly diagnosed myeloma is not related with infused tumor cell load and the outcome is not improved by CD34+ cell selection: long term follow-up of an EBMT phase III randomized study. (English)
Hartmut Goldschmidt
Dietger Niederwieser
Hildegard Greinix
Jean-Henri Bourhis
Yasmina Bouko
Serge Koscielny
Marleen Bakkus
Gunter Derigs
Gilles Salles
Walter Feremans
Jane Apperley
Diana Samson
Bo Björkstrand
Gösta Gahrton
José-Luis Pico
European Group for Blood and Marrow Transplantation
20 July 2007
92
8
1083-1090